Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Immuno-oncology Therapy market report explains the definition, types, applications, major countries, and major players of the Immuno-oncology Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Roche
Bristol-Myers Squibb
Merck
Sanofi
AstraZeneca
Spectrum Pharmaceuticals
Janssen Biotech
Pfizer
GlaxoSmithKline
Eli-Lilly
Takeda
Amgen
Novartis
By Type:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
By End-User:
Hospitals
Ambulatory Surgical Center
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Immuno-oncology Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Immuno-oncology Therapy Outlook to 2028- Original Forecasts
-
2.2 Immuno-oncology Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Immuno-oncology Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Immuno-oncology Therapy Market- Recent Developments
-
6.1 Immuno-oncology Therapy Market News and Developments
-
6.2 Immuno-oncology Therapy Market Deals Landscape
7 Immuno-oncology Therapy Raw Materials and Cost Structure Analysis
-
7.1 Immuno-oncology Therapy Key Raw Materials
-
7.2 Immuno-oncology Therapy Price Trend of Key Raw Materials
-
7.3 Immuno-oncology Therapy Key Suppliers of Raw Materials
-
7.4 Immuno-oncology Therapy Market Concentration Rate of Raw Materials
-
7.5 Immuno-oncology Therapy Cost Structure Analysis
-
7.5.1 Immuno-oncology Therapy Raw Materials Analysis
-
7.5.2 Immuno-oncology Therapy Labor Cost Analysis
-
7.5.3 Immuno-oncology Therapy Manufacturing Expenses Analysis
8 Global Immuno-oncology Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Immuno-oncology Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Immuno-oncology Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Immuno-oncology Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Immuno-oncology Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Immuno-oncology Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Surgical Center Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Immuno-oncology Therapy Market Analysis and Outlook till 2022
-
10.1 Global Immuno-oncology Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Immuno-oncology Therapy Consumption (2017-2022)
-
10.2.2 Canada Immuno-oncology Therapy Consumption (2017-2022)
-
10.2.3 Mexico Immuno-oncology Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.2 UK Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.3 Spain Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.4 Belgium Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.5 France Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.6 Italy Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.7 Denmark Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.8 Finland Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.9 Norway Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.10 Sweden Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.11 Poland Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.12 Russia Immuno-oncology Therapy Consumption (2017-2022)
-
10.3.13 Turkey Immuno-oncology Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.2 Japan Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.3 India Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.4 South Korea Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.5 Pakistan Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.7 Indonesia Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.8 Thailand Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.9 Singapore Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.10 Malaysia Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.11 Philippines Immuno-oncology Therapy Consumption (2017-2022)
-
10.4.12 Vietnam Immuno-oncology Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Immuno-oncology Therapy Consumption (2017-2022)
-
10.5.2 Colombia Immuno-oncology Therapy Consumption (2017-2022)
-
10.5.3 Chile Immuno-oncology Therapy Consumption (2017-2022)
-
10.5.4 Argentina Immuno-oncology Therapy Consumption (2017-2022)
-
10.5.5 Venezuela Immuno-oncology Therapy Consumption (2017-2022)
-
10.5.6 Peru Immuno-oncology Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Immuno-oncology Therapy Consumption (2017-2022)
-
10.5.8 Ecuador Immuno-oncology Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Immuno-oncology Therapy Consumption (2017-2022)
-
10.6.2 Kuwait Immuno-oncology Therapy Consumption (2017-2022)
-
10.6.3 Oman Immuno-oncology Therapy Consumption (2017-2022)
-
10.6.4 Qatar Immuno-oncology Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Immuno-oncology Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Immuno-oncology Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Immuno-oncology Therapy Consumption (2017-2022)
-
10.7.2 South Africa Immuno-oncology Therapy Consumption (2017-2022)
-
10.7.3 Egypt Immuno-oncology Therapy Consumption (2017-2022)
-
10.7.4 Algeria Immuno-oncology Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Immuno-oncology Therapy Consumption (2017-2022)
-
10.8.2 New Zealand Immuno-oncology Therapy Consumption (2017-2022)
11 Global Immuno-oncology Therapy Competitive Analysis
-
11.1 Roche
-
11.1.1 Roche Company Details
-
11.1.2 Roche Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Roche Immuno-oncology Therapy Main Business and Markets Served
-
11.1.4 Roche Immuno-oncology Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bristol-Myers Squibb
-
11.2.1 Bristol-Myers Squibb Company Details
-
11.2.2 Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bristol-Myers Squibb Immuno-oncology Therapy Main Business and Markets Served
-
11.2.4 Bristol-Myers Squibb Immuno-oncology Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Merck
-
11.3.1 Merck Company Details
-
11.3.2 Merck Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Merck Immuno-oncology Therapy Main Business and Markets Served
-
11.3.4 Merck Immuno-oncology Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sanofi
-
11.4.1 Sanofi Company Details
-
11.4.2 Sanofi Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sanofi Immuno-oncology Therapy Main Business and Markets Served
-
11.4.4 Sanofi Immuno-oncology Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 AstraZeneca
-
11.5.1 AstraZeneca Company Details
-
11.5.2 AstraZeneca Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 AstraZeneca Immuno-oncology Therapy Main Business and Markets Served
-
11.5.4 AstraZeneca Immuno-oncology Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Spectrum Pharmaceuticals
-
11.6.1 Spectrum Pharmaceuticals Company Details
-
11.6.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Main Business and Markets Served
-
11.6.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Janssen Biotech
-
11.7.1 Janssen Biotech Company Details
-
11.7.2 Janssen Biotech Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Janssen Biotech Immuno-oncology Therapy Main Business and Markets Served
-
11.7.4 Janssen Biotech Immuno-oncology Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Pfizer
-
11.8.1 Pfizer Company Details
-
11.8.2 Pfizer Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Pfizer Immuno-oncology Therapy Main Business and Markets Served
-
11.8.4 Pfizer Immuno-oncology Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GlaxoSmithKline
-
11.9.1 GlaxoSmithKline Company Details
-
11.9.2 GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GlaxoSmithKline Immuno-oncology Therapy Main Business and Markets Served
-
11.9.4 GlaxoSmithKline Immuno-oncology Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Eli-Lilly
-
11.10.1 Eli-Lilly Company Details
-
11.10.2 Eli-Lilly Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Eli-Lilly Immuno-oncology Therapy Main Business and Markets Served
-
11.10.4 Eli-Lilly Immuno-oncology Therapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Takeda
-
11.11.1 Takeda Company Details
-
11.11.2 Takeda Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Takeda Immuno-oncology Therapy Main Business and Markets Served
-
11.11.4 Takeda Immuno-oncology Therapy Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Amgen
-
11.12.1 Amgen Company Details
-
11.12.2 Amgen Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Amgen Immuno-oncology Therapy Main Business and Markets Served
-
11.12.4 Amgen Immuno-oncology Therapy Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Novartis
-
11.13.1 Novartis Company Details
-
11.13.2 Novartis Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Novartis Immuno-oncology Therapy Main Business and Markets Served
-
11.13.4 Novartis Immuno-oncology Therapy Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Immuno-oncology Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global Immuno-oncology Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Immuno-oncology Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Ambulatory Surgical Center Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Immuno-oncology Therapy Market Analysis and Outlook to 2028
-
13.1 Global Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.5 France Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.3 India Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Immuno-oncology Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Immuno-oncology Therapy
-
Figure of Immuno-oncology Therapy Picture
-
Table Global Immuno-oncology Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Immuno-oncology Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Center Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Table North America Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure United States Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure Germany Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure France Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure China Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table South America Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure Brazil Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure Bahrain Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure Nigeria Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure Australia Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table Roche Company Details
-
Table Roche Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Immuno-oncology Therapy Main Business and Markets Served
-
Table Roche Immuno-oncology Therapy Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Immuno-oncology Therapy Main Business and Markets Served
-
Table Bristol-Myers Squibb Immuno-oncology Therapy Product Portfolio
-
Table Merck Company Details
-
Table Merck Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Immuno-oncology Therapy Main Business and Markets Served
-
Table Merck Immuno-oncology Therapy Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Immuno-oncology Therapy Main Business and Markets Served
-
Table Sanofi Immuno-oncology Therapy Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Immuno-oncology Therapy Main Business and Markets Served
-
Table AstraZeneca Immuno-oncology Therapy Product Portfolio
-
Table Spectrum Pharmaceuticals Company Details
-
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Main Business and Markets Served
-
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Product Portfolio
-
Table Janssen Biotech Company Details
-
Table Janssen Biotech Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Immuno-oncology Therapy Main Business and Markets Served
-
Table Janssen Biotech Immuno-oncology Therapy Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Immuno-oncology Therapy Main Business and Markets Served
-
Table Pfizer Immuno-oncology Therapy Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Immuno-oncology Therapy Main Business and Markets Served
-
Table GlaxoSmithKline Immuno-oncology Therapy Product Portfolio
-
Table Eli-Lilly Company Details
-
Table Eli-Lilly Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli-Lilly Immuno-oncology Therapy Main Business and Markets Served
-
Table Eli-Lilly Immuno-oncology Therapy Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Immuno-oncology Therapy Main Business and Markets Served
-
Table Takeda Immuno-oncology Therapy Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Immuno-oncology Therapy Main Business and Markets Served
-
Table Amgen Immuno-oncology Therapy Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Immuno-oncology Therapy Main Business and Markets Served
-
Table Novartis Immuno-oncology Therapy Product Portfolio
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Table North America Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure China Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
